CDKN1A and colorectal cancer: Wang et al found that LincRNA-p21 suppressed metastasis and promoted the clinical survival rate of patients with colorectal cancer through improving the therapeutic efficacy and suppressing the proteins involved in Wnt/β-catenin regulatory pathway [21].